Next Article in Journal
Promoted Ru/PrOx Catalysts for Mild Ammonia Synthesis
Previous Article in Journal
Are Rh Catalysts a Suitable Choice for Bio-Oil Reforming? The Case of a Commercial Rh Catalyst in the Combined H2O and CO2 Reforming of Bio-Oil
Previous Article in Special Issue
Boosting Benzene’s Ozone Catalytic Oxidation at Mild Temperatures over Highly Dispersed Ag-Doped Mn3O4
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

UiO-67 Metal–Organic Framework as Advanced Adsorbent for Antiviral Drugs from Water Environment

by
Sitah Almotiry
1,2,
Basma G. Alhogbi
1,*,
Mohamed Abdel Salam
1,* and
Mariusz Jaremko
3
1
Chemistry Department, Faculty of Science, King Abdulaziz University, P.O. Box 80200, Jeddah 21589, Saudi Arabia
2
Department of Chemistry, College of Science, Qassim University, P.O. Box 1162, Buraidah 51452, Saudi Arabia
3
Environmental Science and Engineering (BESE) Division, King Abdullah University of Science and Technology (KAUST), P.O. Box 4700, Thuwal 23955, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Catalysts 2024, 14(9), 573; https://doi.org/10.3390/catal14090573 (registering DOI)
Submission received: 8 July 2024 / Revised: 6 August 2024 / Accepted: 19 August 2024 / Published: 29 August 2024
(This article belongs to the Special Issue Catalytic Energy Conversion and Catalytic Environmental Purification)

Abstract

:
Metal–organic frameworks (MOFs) have attained significant usage as adsorbents for antiviral medicines in contemporary times. This study focused on synthesizing a UiO-67 metal–organic framework using the hydrothermal method. The synthesized framework was then characterized using Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), thermogravimetric analyses (TGA), and zeta potential measurements. The UiO-67 was then employed for the purpose of assessing the efficiency of various adsorption factors in the removal of antiviral medicines from aqueous solutions, including drugs such as ritonavir (RTV) and lopinavir (LPV), which were extensively used for the treatment of coronavirus (COVID-19) during the pandemic. The variables examined were the quantity of adsorbent used, different pH of the solution, temperature, and contact duration. The experimental findings indicate that the highest level of RTV elimination was 91.2% and of experimental adsorption capacity (qe,exp) was 9.7 mg/g and for LPV this was 85.9%, and (qe,exp) 8.9 mg/g, using 50 mg of UiO-67 at a pH 8, temperature of 298 K, and for 120 min. The impact of contact duration and temperature on the kinetics of adsorption was examined by employing pseudo-first-order and pseudo-second-order kinetic models. The experimental results showed a good match with the pseudo-second-order kinetic model with value of R2 0.99 and the qe,calc was 9.7 RTV and 8.9 mg/g LPV, which is a good match with qe,exp. Also, based on diffusion kinetic studies, the adsorption was confirmed to be catalytic in nature on the surface of the UiO-67 MOFs. A thermodynamic analysis of adsorption was conducted, whereby calculations for the Gibbs free energy change (∆G), enthalpy change (∆H), and entropy change (∆S) were performed. The positive ∆H values confirm the endothermic nature of the adsorption of RTV and LPV by UiO-67. The ΔG values exhibited negativity across all temperatures, suggesting the spontaneous nature of the adsorption process of RTV and LPV by UiO-67 from an aqueous solution. UiO-67 was shown to be highly effective in extracting RTV and LPV from real environmental samples.

1. Introduction

Over the past few decades, there has been a growing recognition of pharmaceutical compounds and their metabolites as a major source of water pollution, exerting a considerable influence on the worldwide environment [1,2]. The substantial utilization of some pharmaceutical compounds in recent years has resulted in an escalation of their levels in urban wastewater [3,4]. Among the widely used antivirals are ritonavir (RTV) are lopinavir (LPV) [5,6]. These pharmaceuticals have gained attention as emerging organic contaminants (EOCs) because of their recent utilization in the treatment of COVID-19 [7,8,9]. Also, LPV and RTV were detected in the wastewater effluent (41.0 ng/L and 4.8 ng/L), downstream of municipal wastewater treatment plants (31.5 ng/L and 5.8 ng/L), and surface water in Wuhan, China (4.7 ng/L and 4.2 ng/L) [10], and South Africa sewage treatment plants (maximum mean concentration 2.5 µg/L and 3.2 µg/L, respectively [11]. The existence of EOCs in water has been found to have adverse effects on the reproductive, neurological, and immunological systems of both aquatic organisms and human beings [12], especially RTV, and LPV [13,14]. The buildup of these medications in aquatic creatures presents a significant environmental concern, as indicated by previous studies [15,16]. Hence, the elimination of pharmaceutical compounds from water sources presents an imperative task, necessitating the exploration and implementation of alternative methodologies. There are many technologies used for the elimination of antiviral drugs such as RTV and LPV from aquatic environment, such as adsorption by sludge [17], photocatalysis [18], photolosis (UV) [19], membrane bioreactor and ozonation [20], electrochemical advanced oxidation process [21], and activated sludge [22]. The efficiency of adsorption technology in the removal of pharmaceutical pollutants from discarded water has been recognized, along with its economic advantages stemming from its efficient target absorption, high removal rate, and ease of operation [23,24]. Many adsorptive materials have been extensively studied for the purpose of pharmaceutical removal. These materials encompass silica-based materials [25,26], resins [27], metal oxides [28], activated carbon [29], and graphene oxide [30]. In recent times, there has been a growing interest in metal–organic frameworks (MOFs) as very promising adsorbents for liquid-phase adsorption [31,32,33,34]. MOFs are a highly sophisticated category of porous crystalline materials that exhibit intriguing structures and features. These include the presence of several aromatic organic ligands and Lewis’s acid sites, a large surface area, the ability for surface functionalization, and a diverse range of shapes and topologies [35,36,37].
In 1995, the first MOF with a three-dimensional open skeleton structure was developed by Yaghi et al. [38]. Since then, various excellent MOFs have been constructed in large quantities and there are various reports about water remediation by MOFs. Karimi and Namazi et al. (2024) utilized hydrogel beads of a magnetic graphene oxide@MIL-88 metal–organic framework (GO@Fe3O4@MIL-88@Alg) for the absorption of treatments used for COVID-19 such as doxycycline (DOX), hydroxychloroquine (HCQ), naproxen (NAP), and dipyrone (DIP) from aquatic environment [39]. Pharmaceutical drugs and personal care products (PPCPs) were treated by the manufacture of a Pd@ MIL-100 (Fe) nanocomposite [40]. The widespread use of MOFs is mostly related to the stability of the water in environmental remediation [41,42]. The University of Oslo (UiO) series, the Material of Institute Lavoisier (MIL) series, and the Zeolitic Imidazolate Framework (ZIF) series materials are common water-stable MOFs [38]. The MOFs of UiO-67 are a member of the UiO Zr-MOF family, which is characterized by its microporous nature [43,44,45,46]. This type of MOF has wide applications due to its thermal and chemical composition and mechanical stability [47,48,49,50].
The main objective of the current study is aquatic environmental sustainability through the remediation of water polluted with organic pollutants such as antiviral drugs. The novelty of the current study involved the synthesis of UiO-67 metal–organic frameworks using the hydrothermal technique and their application, for the first time, to remove RTV and LPV as antivirals drugs from aqueous solutions.
The morphological and structural characteristics of the synthesized UiO-67 will be investigated. The adsorption process will be studied with different parameters such as pH of the solution, different temperatures, varied UiO-67 mass, and contact duration. The adsorption process will be studied kinetically and thermodynamically. The treatment and removal of RTV and LPV from real water samples will also be explored by UiO-67 via an adsorption procedure.

2. Results and Discussion

2.1. Characterization of UiO-67

Solvothermal preparation was used to create the UiO-67. The powder XRD pattern in Figure 1A confirms that the synthesized materials display a typical cubic close-packed structure that is consistent with the work that has been previously reported [51,52]. A thermal gravimetric analysis (TGA) was conducted on a sample of UiO-67. As depicted in Figure 1B, the thermal gravimetric analysis (TGA) of the specimen exhibits three distinct phases: initial evaporation of the solvent at around 100 °C, subsequent removal of the compensatory agent at around 450 °C, and eventual disintegration of the framework within the temperature range of 450 °C to 600 °C. Considering the structural characteristics of the sample UiO-67, this study examines the percentage of mass loss (% ZrO2) in the temperature range of 450 °C to 600 °C, which was around 65%. The same observations were reported previously for UiO-67 [53], UiO-66 MOFs [54], and zeolitic tetrazolate imidazole frameworks (ZTIFs) [55]. The UiO-67 material had an average zeta potential value of +20.8 mV, indicating a satisfactory level of stability Figure 1C in accordance with previous reported work [56]. A higher magnitude of zeta potential signifies enhanced physical colloidal stability as a result of electrostatic repulsion among the constituent particles. In the N2 adsorption–desorption isotherms shown in Figure 1D, UiO-67 demonstrates a type-I isotherm, indicating that it is a characteristic microporous material [57], with a BET specific surface area of 1415 m2/g, whereas the average pore width and the pore volume of the UiO-67 channels were 2.06 nm and 0.801 cm3/g, respectively, which agreed well with previous reported value for different MOFs such as UiO-67 [56], MIL-53(Al) MOFs modified with rice husk [58], MIL-53(Al) modified by biomass hydrochar [59], and sulfonic-functionalized MIL-100-Fe MOF [60]. In the FTIR spectra presented in Figure 2A, the absorption bands at 3382 cm−1 are ascribed to hydrogen bonding. The peaks detected at 1600 and 1581 cm−1 are assigned to the coordinated carboxylate groups (COO-). The strong peak detected at 1418 cm−1 is assigned to the skeletal vibrations of the benzene ring (C=C). The morphology of UiO-67 depicted by SEM in Figure 2B,C, where the octahedral structure of Zr-MOF crystals is visible with an average crystal dimension of 450 nm, is in accordance with a previous reported study [61].

2.2. Adsorption Parameter

The parameters encompassed in this study are contact time, UiO-67 mass, and solution conditions including pH and temperature. Therefore, the effect of different factors on the interaction between UiO-67 and RTV and LPV was explored and studied. Figure 3A shows the effect of a different UiO-67 mass on the removal of RTV and LPV. The mass added started with 5 mg of UiO-67; the percentage removal was 7.9% of RTV and 4.6% of LPV after 60 min. The removal percentage of RTV and LPV gradually increased with the increasing amount of UiO-67 added: 50 mg resulted in 92.3% of the RTV and 86.5% of LPV. These percentages of RTV and LPV removed increased by adding 70 mg UiO-67 to the solution until they reached 94.2% and 97.6% removal of RTV and LPV, respectively. A further increase in the amount of UiO-67 to 100.0 mg increased the % removal of RTV to almost 99.2%, and of LPV to 94.9%, after 60 min. It is clear from the findings that there is an increase in the % removal of RTV and LPV with the increase in UiO-67 mass.
The influence of solution pH on the removal process is a significant physico-chemical component that affects the adsorption mechanism at the interface between the solid and solution. Hence, an investigation was conducted to examine the impact of solution pH on the elimination of RTV and LPV by the utilization of UiO-67. The pH levels ranged from 2.0 to 12.0, and the corresponding results in Figure 3B show that the maximum elimination was seen at pH 8 as 95.6% for RTV and 79.9% for LPV, which is the optimal pH value. Figure 3C shows the impact of solution temperature on the adsorption process for RTV and LPV. Additionally, as the temperature of the solution increased, there was a progressive increase in the removal % of RTV and LPV.
Figure 4 shows the dependence of the % removed of RTV and LPV by UiO-67 on the contact time at different temperatures, 296 K, 308 K, and 322 K. In general, Figure 4 shows that the percentage of adsorption of the RTV and LPV by UiO-67 after 5.0 min at 296 K was 91.2% for RTV and 85.9% for LPV, and at 308 K the removal percent was increased to 91.7% for RTV and 86.9% for LPV. The results showed that by increasing the temperature to 322 K, the removal percentage also increased to 92.7% for RTV and 89.3% for LPV. Meanwhile, increasing the contact time by more than 10.0 min slowly increased the removal percentage until it reached 97.4% and 89.46% at 296 K, 96.9% and 94.4% at 308 K, and 99.5% and 95.3% at 322 K for RTV and LPV, respectively. Figure 4 shows the effect of contact time on the removal of RTV and LPV by the UiO-67 as a function of amount removed. The amount removed after 5.0 min by UiO-67 was 9.2, 9.0, and 9.3 mg/g of RTV at 296 K, 302 K, and 322 K, respectively. The amount removed for LPV after 5 min was 8.6, 8.7, and 8.9 mg/g LPV by UiO-67 at 296 K, 302 K, and 323 K. Increasing the contact time was associated with a slight increase in the amount removed until it became constant after 60 min with amount removed of RTV being 9.6, 9.7, and 9.9 mg/g at 296 K, 302 K, and 323 K, respectively, and the amount removed of LPV being 8.9, 9.4, and 9.5 mg/g at 296 K, 308 K, and 322 K, respectively. Overall, the data shown in the results indicate that the process of adsorption exhibited endothermic behavior.

2.3. Adsorption Kinetics Models

To obtain a comprehensive understanding of the adsorption and remediation process, it is imperative to conduct a thorough investigation of the kinetic adsorption process. This entails closely monitoring the experimental variables that may influence the rate of adsorption, thereby facilitating the achievement of equilibrium within a suitable period. These investigations provide insights into the potential adsorption process and the transitional phases involved in the production of the ultimate adsorbate–adsorbent complex. Once the reaction rates and their corresponding dependent parameters have been definitively determined, this knowledge might apply to the development of adsorbent materials for commercial purposes. Additionally, it will contribute to a deeper understanding of the intricate dynamics involved in the process of adsorption.
The adsorption of RTV and LPV into UiO-67 was applied to pseudo-first-order model Equation (8) by plotting ln (qeqt) vs. t; RTV and LPV at different temperatures did not converge well and did not give straight lines with an R2 value of 0.66 as is clear from Figure 5, with unacceptable regression coefficients, as is presented in Table 1 and Table 2. Also, the estimated values of the amount adsorbed at equilibrium (qe,calc) were not close to the experimental values (qe,exp). This indicated that the adsorption of the RTV and LPV by UiO-67 could not described by the pseudo-first-order Lagergren equation.
The linearized form of pseudo-second-order rate Equation (9) for the adsorption of RTV and LPV onto UiO-67 by plotting t/qt vs. t is presented in Figure 5A; good converging was obtained to the experimental data and the straight lines obtained gave excellent regression coefficients (R2 > 0.99), as is presented in Table 1 and Table 2.
These findings confirm the suitability of the pseudo-second-order rate equation for the description of RTV and LPV adsorption by UiO-67 from aqueous solution. Also, it is clear from the results that the amount adsorbed per unit mass of UiO-67 at equilibrium (qe,calc) calculated from the slope of the pseudo-second-order plot was in good agreement with the experimental values (qe,exp), as is presented in Table 1 and Table 2. These findings agreed well with previous studies and showed the suitability of the pseudo-second-order kinetic model to describe the removal process of different pharmaceuticals, personal care products, dyes, and endocrine-disrupting chemicals (EDCs) in aqueous solution, such as graphene nanoplatelets for the removal of aspirin, acetaminophen, and caffeine [62], Multiwalled Carbon Nanotubes for the decolorization of methylene blue cationic dye [63], the removal of Ketoprofen and Ibuprofen by an Al/Ni-layered double-hydroxide onto polyaniline-wrapped sisal fibers [64], the removal of hydroxychloroquine sulfate by cocoa shell activated carbon [65], the adsorption of metronidazole antibiotic from water with a stable Zr(IV)-MOFs [54], adsorption of the antiviral drugs (oseltamivir and ritonavir) by zeolitic tetrazolate imidazole frameworks (ZTIFs) [55], adsorption of glyphosate by a MIL-53(Al)@rice husk hybrid [58], MIL-53(Al) modified by biomass hydrochar for the removal of ketorolac and naproxen [59], and the removal of diclofenac by the sulfonic-functionalized MIL-100-Fe MOF from aqueous solution [60].

2.4. Adsorption Rate-Controlling Mechanism

The adsorption process usually occurs through a series of consecutive steps. Initially, the adsorbate molecules are transported from the bulk aqueous phase to the surface of the stagnant-boundary liquid film surrounding the solid adsorbent. Subsequently, diffusion takes place through the boundary layer, allowing the adsorbate molecules to reach the external surface of the solid adsorbent. At this point, adsorption takes place at an active site on the surface of the solid adsorbent. Finally, intra-particle diffusion and adsorption occur through the pores and aggregates of the solid adsorbent. This section describes an investigation that was conducted to determine the rate-controlling mechanism for the adsorption of RTV and LPV by UiO-67 from an aqueous solution. Two distinct models, namely the liquid film diffusion model and the intra-particle diffusion model, were employed for this purpose. The liquid film diffusion model is another kinetic model that assumes the flow of adsorbed molecules through a liquid film surrounding the solid adsorbent, as in the following Equation (1):
ln ( 1 F ) = k f d × t
where F is the fractional attainment of equilibrium (qt/qe) and kfd (min−1) is the film diffusion rate coefficient. A linear plot of −ln(1 − F) vs. t with zero intercept suggests that the kinetics of the adsorption process is controlled by liquid film. The rate of diffusion within particles is expressed by the following Equation (2):
q e = k i d t 1 l 2 + C i
where kid (mg/g·min) is the intra-particle diffusion constant. As shown in Figure 6A,B, the experimental data for absorption of RTV and LPV by UiO-67 were analyzed using an intra-particle diffusion model.
The use of the liquid film diffusion model to analyze the adsorption data of RTV and LPV by UiO-67 exhibited moderate convergence and yielded moderate linear regression coefficients, as depicted in Figure 6C,D and Table 1 and Table 2. However, the use of the intra-particle diffusion model to analyze the experimental data did not provide straight lines passing through the origin, resulting in unsatisfactory linear regression coefficients, as shown in Table 1 and Table 2. The convergence and the linear regression of the liquid film diffusion model are much better than the intra-particle diffusion model, which may indicate that the adsorption processes of RTV and LPV by UiO-67 occur mainly on the surface of the UiO-67 active sites, and not inside the pores of the UiO-67. These results suggested that the adsorption was catalytic in nature on the surface of the UiO-67 MOFs due to the interaction of the RTV and LPV with the active sites present on the UiO-67 surface. It is well known in heterogeneous catalysis reactions that reactants diffuse from the bulk fluid phase to adsorb on the catalyst surface, which in this case is the solid adsorbent UiO-67. So, the adsorbate molecules (RTV and LPV), must migrate across the surface to an active site of the UiO-67, where RTV and LPV molecules are adsorbed and immobilized physically to form physical bonds with the UiO-67 (product) by following a more energetically facile path through catalytic intermediates, as the adsorption takes place in different intermediate steps, and the adsorption rate is affected by different factors including solution temperature and mass transfer. After the desorption process, the active site on the MOF adsorbent is available for another cycle of adsorption [49].

2.5. Thermodynamic Studies

The adsorption of RTV and LPV by UiO-67 was studied thermodynamically to explore the spontaneity of the process. Different thermodynamic parameters were calculated, Gibbs free energy change (ΔG), enthalpy change (ΔH), and entropy change (ΔS) from the variation in the thermodynamic distribution coefficient D with a change in temperature according to Equation (3), and the ΔH and ΔS were calculated according to the Equation (4):
D = q e C e
l n D = Δ S ° R Δ H °   2.303   R T
where R is the gas constant (8.314 J/(mol K)), T is the absolute temperature (K), and D is the distribution coefficient of the adsorbate.
When plotting lnD vs. 1/T for the adsorption of RTV and LPV by UiO-67, straight lines were obtained, as presented in Figure 7. The ΔH and ΔS values were calculated from the slope and the intercept of the straight line. The ∆H values were positive, +23.5 kJ/mole and +24.4 kJ/mole for the adsorption of RTV and LPV, respectively, by UiO-67 from aqueous solution. The positive ∆H values confirm the endothermic nature of the adsorption of RTV and LPV by UiO-67, which explains the increase in adsorption with the rising solution temperature. Also, the values of ∆H suggests a strong affinity between RTV and LPV for UiO-67, and the physical nature of the adsorption. The positive values of ∆S, +36.2 KJ/mole for RTV and +40.3 KJ/mole for LPV, suggested an increase in the degree of randomness at the UiO-67 solution interface during the adsorption and immobilization of RTV and LPV. The ΔG values were calculated for 296 K using the following Equation (5):
Δ G ° = Δ H ° T Δ S °
The adsorption of RTV and LPV by UiO-67 was spontaneous, as indicated by the negative values of the calculated free energy change, ∆G −6.9 kJ/mole and −7.2 kJ/mole for the adsorption of RTV and LPV, respectively, by UiO-67 from aqueous solution. Generally, the negative values of ∆G positive values of ∆H and ∆S suggested that the adsorption of RTV and LPV by UiO-67 process is an entropy-driven process.

3. Environmental Applications

The present study aimed to assess the effectiveness of UiO-67 as a solid adsorbent for the removal of RTV and LPV from real water samples. For this investigation, a selection of five samples was chosen, including sea water, wastewater, well water, tap water, and bottled water. The amounts of RTV and LPV were measured first, and it was found that they were below the detection limit of the HPLC method. This suggests that the selected water samples were free from these pollutants. Consequently, the real water samples were spiked with RTV and LPV, with a resultant concentration of 50.0 mg/L for both RTV and LPV, and then the real samples were equilibrated overnight.
Following this, an amount of 50.0 mg of UiO-67 was added to the spiked samples and left for 60 min. The amount adsorbed was calculated by comparing the concentrations of RTV and LPV before and after the adsorption, and the results are presented in Figure 8. The data shown in Figure 8 demonstrate that around 90% of RTV and LPV was removed from the spiked real water samples, confirming the applicability of UiO-67 for environmental remediation, especially in the case of pollution with antiviral drugs such as RTV and LPV.

4. Materials and Methods

4.1. Materials

The chemical reagents employed in the production of UiO-67 include Zirconium tetrachloride (ZrCl4) 98%, which was purchased from Energy Chemical (Shanghai, China), 4,4′-biphenyldicarboxylic acid (BPDC) 98%, obtained from Tianjin Hewns Biochem LLC. (Tianjin, China), acetic acid, hydrochloric acid (HCl) at a concentration of 37%, dimethylformamide (DMF) 99%, and acetone 96%, which were obtained from Shenzhen Biocomma Biotech (Shenzhen, China). The pharmaceutical drugs, ritonavir (RTV) and lopinavir (LPV), the chemical composition is shown in Figure 9, were purchased from Sigma–Aldrich (Darmstadt, Germany) at an analytical purity of 98%. All solutions were prepared using deionized water.

4.2. Preparation of UiO-67

The UiO-67 metal–organic framework (MOF) was synthesized as shown in Scheme 1 using a mixture of ZrCl4 (233 mg, 1 mmol), 4,4′-biphenyldicarboxylic acid (BPDC, 242 mg, 1 mmol), acetic acid (0.6 g, 10 mmol), and HCl (37%, 12 M; 0.16 mL, 2 mmol) mixed in 30 mL of N, N-dimethylformamide (DMF) using the process of sonication. The mixture was placed in a 100 mL Teflon-lined stainless-steel autoclave and heated at 120 °C for 48 h. Subsequently, the UiO-67 white product was obtained by the process of centrifugation and subjected to three rounds of washing with DMF. The UiO-67 material, in its original form, was immersed in DMF at ambient temperature for a duration of 6 h in order to eliminate any residual BPDC that was not bound. Subsequently, the particles that were acquired underwent several washes with acetone to facilitate the displacement of the entrapped DMF, followed by a drying process at a temperature of 100 °C for a duration of 24 h, as shown in Scheme 1.

4.3. Characterization of UiO-67

Powder XRD (X-ray diffraction) patterns were obtained using a D8 ADVANCE ECO (Bruker, Billerica, MA, USA) with Cu Kα radiation (40 kV, 40 mA) at a rate of 6° min−1 over a range of 4–40° (2θ). The thermogravimetric analyses (TGA) were carried out using a TG/SDTQ600 (USA) instrument in atmosphere within a temperature range of 0.0–900 K at a heating rate of 10 °C m i n 1  under a nitrogen flow of 100 mL m i n 1 with open alumina pans. The morphology of the samples was examined by using a scanning electron microscope (SEM, JSM-6701F, Tokyo, Japan). The FTIR spectra were recorded using a FTIR spectrophotometer (Spectrum 100, Perkin Elmer, Shelton, CT, USA). The zeta potential was obtained through measurement of the electrophoretic mobility of the particles using a Zeta sizer (Malvern Instruments GmbH, Malvern, WR14 1XZ, UK). Nitrogen adsorption–desorption isotherms were measured by using a N2 porosimeter (Tristar 3020, Micromeritics, Norcross, GA, USA) at 77 K; the samples were degassed at 150 °C for 12 h under vacuum before this analysis.

4.4. Analytical Method

The concentrations of RTV and LPV were determined using high-performance liquid chromatography (HPLC) with a Hewlett Packard 1100 series liquid chromatograph (Avondale, CA, USA). The high-performance liquid chromatography (HPLC) system was comprised of two pumps and a UV detector. The separations were conducted using an analytical reversed-phase C18 column with dimensions of 4.6 mm × 150 mm and a particle size of 5 μm. The mobile phase flow rate was set at 1.5 mL/min, and gradient conditions were employed. The mobile phase consisted of a combination of deionized water with 1% formic acid and acetonitrile, with a volume ratio of 40:60. A volume of 10 μL was utilized for the injected sample size, while the detection wavelength for UV analysis was set at 254 nm. The chromatogram results are shown in Figure 10.

4.5. Adsorption Studies

Adsorption tests were conducted in the study to investigate the impact of several adsorption factors, including adsorbent mass, solution pH, solution temperature, and adsorption time. A set of 10.0 mL solutions, each containing 50.0 mg/L of lopinavir and ritonavir, were created in 25.0 mL glass bottles and maintained at a certain temperature. A test for the effect of UiO-67 mass was performed by using different masses (0, 5, 10, 15, 30, 50, 70, and 100 mg) in 10 mL of diluted RTV and LPV drug mixture and 60 min contact time at 296 K. A test for the effect of solution pH was performed by using different pH values (2, 4, 6, 8, and 11) that were adjusted using HCl solution and NaOH solution and using 50 mg of UiO-67 in 10 mL of diluted drug mixture and 60 min contact time at 296 K. A test for the effect of temperature was performed by measuring the amount adsorbed at different temperatures (280, 294, 302, 308, 313, 318, and 322 K) using 10 mg of UiO-67 in 10 mL of diluted drug mixture and 60 min contact time. A test for the effect of adsorption time was performed by measuring the amount adsorbed at different times (1, 2, 3, 5, 7, 10, 15, 20, 30, 45, 60, 90, and 120 min) using 10 mg of UiO-67 in 10 mL of diluted drug mixture and 60 min contact time at 296 K. Subsequently, the solution was promptly filtered using a filter paper (specifically, Whatman® quantitative filter paper, ashless, Grade 42, 2.5 μm) to collect the supernatant. The concentrations of lopinavir and ritonavir in the aqueous solution were subsequently analyzed using high-performance liquid chromatography (HPLC). Prior to injection, the solution was filtered through a 0.45 μm syringe filter made of cellulose acetate. This filtration step was implemented to ensure that the injected solution did not contain any UiO-67, which could potentially obstruct the HPLC column and lead to inaccurate findings. The percentage of removal in the solution was determined by utilizing Equation (6) [35]:
R e m o v a l   % = C i C e C i × 100
where Ci is the initial concentration and Ce is the equilibrium concentration of RTV and LPV in solution (mg/L).
The adsorption capacity at any time was calculated according to the following Equation (7):
q e = C i C e m × V
where qe is the amount of RTV and LPV adsorbed by the UiO-67 (mg/g) at equilibrium, V is the initial solution volume (L), and m is the mass of UiO-67 (g). It is noteworthy to mention that each experiment was performed in triplicate and the reported values are the average of three measurements.
The adsorption process of RTV and LPV by solid adsorbents such as UiO-67 was applied to the most used kinetic models: Lagergren pseudo-first-order model Equation (8) and the pseudo-second-order Equation (9) [50,51]:
ln q e q t = log q e k 1 2.303 t
t q t = 1 k 2 q e 2 + 1 q e t
where k1 (min−1) is the pseudo-first-order rate coefficient, k2 (g/(mg·min)) is the pseudo-second-order rate coefficient, and qe and qt are the values of the amount absorbed per unit mass mg/g at equilibrium and at any time t, respectively.

4.6. Real Water Samples

Five environmental water samples were used to evaluate the efficiency of UiO-67 in the removal of lopinavir and ritonavir. The water samples include seawater, sewage water, well water, tap water, and bottled water. The samples underwent filtration using a 0.45 L Millipore filter paper and after that were kept in Teflon bottles at a temperature of 5 °C in the dark.

5. Conclusions

This study investigated the adsorption of antiviral drugs such as RTV and LPV compounds from aqueous solutions onto the metal–organic framework UiO-67. The adsorption experimental findings show that the highest level of adsorption capacity for RTV and LPV was (qe,exp) 9.9 mg/g, which was attained with an efficiency of 91.2% for RTV and 85.9% for LPV using 50 mg of UiO-67 at a temperature of 298 K, pH 8, and duration time 120 min. The adsorption of RTV and LPV on the UiO-67 MOFs followed the second-order-model with R2 0.99, and the data depict that the adsorption capacity at equilibrium was 9.9 mg/g (qe,calc), which is in good agreement with the experimental values (qe,exp). Moreover, the rate-determining step of adsorption was mainly due to the liquid film diffusion, which suggested the catalytic nature of the adsorption mechanism at the surface of the UiO-67 MOFs due to the interaction of the RTV and LPV molecules with the active sites present on the UiO-67 surface. The adsorption was spontaneous, as indicated by the negative values of the calculated free energy change, ∆G −6.9 kJ/mole. Generally, the negative values of ∆G and the positive values of ∆H +24.2 kJ/mole endothermic nature and the ∆S +39.5 KJ/mole suggested that the adsorption of RTV and LPV by UiO-67 process is one of random disorder. The utilization of UiO-67 as an adsorbent has shown significant efficacy in the removal of RTV and LPV from real environmental samples. Therefore, it is evident that UiO-67 has high efficiency and adsorption capabilities as a composite material for the removal of RTV and LPV from aqueous solutions. In future studies, UiO-67’s exhibited potential as a promising adsorbent, capable of effectively facilitating the removal of diverse components through the utilization of adsorption techniques, will be further studied.

Author Contributions

B.G.A.: project administration, supervision, writing—review and editing; S.A.: methodology, formal analysis, writing—original draft; M.A.S.: validation, data assignment, supervision, writing—review and editing; M.J.: data curation, formal analysis. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The data presented in this study are available on request.

Acknowledgments

The authors acknowledge King Abdulaziz University for facilitated the practical work and technical support and would like to thank King Fahd Medical Research Center (KFMRC), King Abdulaziz University for technical support.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lozano, I.; Pérez-Guzmán, C.J.; Mora, A.; Mahlknecht, J.; Aguilar, C.L.; Cervantes-Avilés, P. Pharmaceuticals and personal care products in water streams: Occurrence, detection, and removal by electrochemical advanced oxidation processes. Sci. Total Environ. 2022, 827, 154348. [Google Scholar] [CrossRef] [PubMed]
  2. Kujawska, A.; Kiełkowska, U.; Atisha, A.; Yanful, E.; Kujawski, W. Comparative analysis of separation methods used for the elimination of pharmaceuticals and personal care products (PPCPs) from water—A critical review. Sep. Purif. Technol. 2022, 290, 120797. [Google Scholar] [CrossRef]
  3. Van Boeckel, T.P.; Gandra, S.; Ashok, A.; Caudron, Q.; Grenfell, B.T.; Levin, S.A.; Laxminarayan, R. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect. Dis. 2014, 14, 742–750. [Google Scholar] [CrossRef] [PubMed]
  4. Yin, L.; Wang, B.; Yuan, H.; Deng, S.; Huang, J.; Wang, Y.; Yu, G. Pay special attention to the transformation products of PPCPs in environment. Emerg. Contam. 2017, 3, 69–75. [Google Scholar] [CrossRef]
  5. De Clercq, D. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int. J. Antimicrob. Agents 2009, 33, 307–320. [Google Scholar] [CrossRef]
  6. Chandwani, A.; Shuter, J. Lopinavir/ritonavir in the treatment of HIV-1 infection: A review. Ther. Clin. Risk Manag. 2008, 4, 1023–1033. [Google Scholar]
  7. Patel, T.K.; Patel, P.B.; Barvaliya, M.; Saurabh, M.K.; Bhalla, H.L.; Khosla, P.P. Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials. J. Infect. Public. Health 2021, 14, 740–748. [Google Scholar] [CrossRef]
  8. Çinarka, H.; Günlüoğlu, G.; Çörtük, M.; Yurt, S.; Kiyik, M.; KOŞAR, F.; Tanriverdi, E.; Arslan, M.A.; Baydili, K.N.; Koç, A.S.; et al. The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment. Turk. J. Med. Sci. 2021, 51, 1624–1630. [Google Scholar] [CrossRef]
  9. Gasmi, A.; Noor, S.; Menzel, A.; Khanyk, N.; Semenova, Y.; Lysiuk, R.; Beley, N.; Bolibrukh, L.; Gasmi Benahmed, A.; Storchylo, O.; et al. Potential drugs in COVID-19 management. Curr. Med. Chem. 2024, 20, 3245–3264. [Google Scholar] [CrossRef]
  10. Zhang, Z.; Zhou, Y.; Han, L.; Guo, X.; Wu, Z.; Fang, J.; Hou, B.; Cai, Y.; Jiang, J.; Yang, Z. Impacts of COVID-19 pandemic on the aquatic environment associated with disinfection byproducts and pharmaceuticals. Sci. Total Environ. 2022, 811, 151409. [Google Scholar] [CrossRef]
  11. Nannou, C.; Ofrydopoulou, A.; Evgenidou, E.; Heath, D.; Heath, E.; Lambropoulou, D. Antiviral drugs in aquatic environment and wastewater treatment plants: A review on occurrence, fate, removal and ecotoxicity. Sci. Total Environ. 2020, 699, 134322. [Google Scholar] [CrossRef] [PubMed]
  12. Brillas, E. A critical review on ibuprofen removal from synthetic waters, natural waters, and real wastewaters by advanced oxidation processes. Chemosphere 2022, 286, 131849. [Google Scholar] [CrossRef] [PubMed]
  13. Kumari, M.; Kumar, A. Environmental and human health risk assessment of mixture of COVID-19 treating pharmaceutical drugs in environmental waters. Sci. Total Environ. 2022, 812, 152485. [Google Scholar] [CrossRef] [PubMed]
  14. Kuroda, K.; Li, C.; Dhangar, K.; Kumar, M. Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. Sci. Total Environ. 2021, 776, 145740. [Google Scholar] [CrossRef] [PubMed]
  15. Lee, C.-C.; Hsieh, C.-Y.; Chen, C.S.; Tien, C.-J. Emergent contaminants in sediments and fishes from the Tamsui River (Taiwan): Their spatial-temporal distribution and risk to aquatic ecosystems and human health. Environ. Pollut. 2020, 258, 113733. [Google Scholar] [CrossRef]
  16. Marchant, J. When antibiotics turn toxic. Nature 2018, 555, 431–433. [Google Scholar] [CrossRef]
  17. Krasucka, P.; Rombel, A.; Yang, X.J.; Rakowska, M.; Xing, B.; Oleszczuk, P. Adsorption and desorption of antiviral drugs (ritonavir and lopinavir) on sewage sludges as a potential environmental risk. J. Hazard. Mater. 2022, 425, 127901. [Google Scholar] [CrossRef]
  18. Thi, L.-A.P.; Panchangam, S.C.; Do, H.-T.; Nguyen, V.-H. Prospects and challenges of photocatalysis for degradation and mineralization of antiviral drugs. Nanostruct. Photocatal. 2021, 17, 489–517. [Google Scholar]
  19. Ngumba, E.; Gachanja, A.; Tuhkanen, T. Removal of selected antibiotics and antiretroviral drugs during post-treatment of municipal wastewater with UV, UV/chlorine and UV/hydrogen peroxide. Water Environ. J. 2020, 34, 692–703. [Google Scholar] [CrossRef]
  20. Mascolo, G.; Laera, G.; Pollice, A.; Cassano, D.; Pinto, A.; Salerno, C.; Lopez, A. Effective organics degradation from pharmaceutical wastewater by an integrated process including membrane bioreactor and ozonation. Chemosphere 2010, 78, 1100–1109. [Google Scholar] [CrossRef]
  21. Zhou, Y.; Li, W.; Kumar, V.; Necibi, M.C.; Mu, Y.-J.; Shi, C.-Z.; Chaurasia, D.; Chauhan, S.; Chaturvedi, P.; Sillanpää, M.; et al. Synthetic organic antibiotics residues as emerging contaminants waste-to-resources processing for a circular economy in China: Challenges and perspective. Environ. Res. 2022, 211, 113075. [Google Scholar] [CrossRef] [PubMed]
  22. Yan, X.; Zheng, S.; Huo, Z.; Shi, B.; Huang, J.; Yang, J.; Ma, J.; Han, Y.; Wang, Y.; Cheng, K.; et al. Effects of exogenous N-acyl-homoserine lactones on nutrient removal, sludge properties and microbial community structures during activated sludge process. Chemosphere 2020, 255, 126945. [Google Scholar] [CrossRef]
  23. Rosman, N.; Salleh, W.; Mohamed, M.A.; Jaafar, J.; Ismail, A.F.; Harun, Z. Hybrid membrane filtration-advanced oxidation processes for removal of pharmaceutical residue. J. Colloid. Interface Sci. 2018, 532, 236–260. [Google Scholar] [CrossRef] [PubMed]
  24. Park, J.; Yamashita, N.; Park, C.; Shimono, T.; Takeuchi, D.M.; Tanaka, H. Removal characteristics of pharmaceuticals and personal care products: Comparison between membrane bioreactor and various biological treatment processes. Chemosphere 2017, 179, 347–358. [Google Scholar] [CrossRef]
  25. Piane, M.D.; Vaccari, S.; Corno, M.; Ugliengo, P. Silica-based materials as drug adsorbents: First principle investigation on the role of water microsolvation on ibuprofen adsorption. J. Phys. Chem. A 2014, 118, 5801–5807. [Google Scholar] [CrossRef] [PubMed]
  26. Jin, J.; Feng, T.; Gao, R.; Ma, Y.; Wang, W.; Zhou, Q.; Li, A. Ultrahigh selective adsorption of zwitterionic PPCPs both in the absence and presence of humic acid: Performance and mechanism. J. Hazard. Mater. 2018, 348, 117–124. [Google Scholar] [CrossRef]
  27. Jin, J.; Feng, T.; Ma, Y.; Wang, W.; Wang, Y.; Zhou, Q.; Li, A. Novel magnetic carboxyl modified hypercrosslinked resins for effective removal of typical PPCPs. Chemosphere 2017, 185, 563–573. [Google Scholar] [CrossRef]
  28. Zhang, Y.; Zhu, H.; Szewzyk, U.; Lübbecke, S.; Geissen, S.U. Removal of emerging organic contaminants with a pilot-scale biofilter packed with natural manganese oxides. Chem. Eng. J. 2017, 317, 454–460. [Google Scholar] [CrossRef]
  29. Tian, W.; Zhang, H.; Duan, X.; Sun, H.; Tade, M.O.; Ang, H.M.; Wang, S. Nitrogen-and sulfur-codoped hierarchically porous carbon for adsorptive and oxidative removal of pharmaceutical contaminants. ACS Appl. Mater. Interfaces 2016, 8, 7184–7193. [Google Scholar] [CrossRef]
  30. Zambianchi, M.; Durso, M.; Liscio, A.; Treossi, E.; Bettini, C.; Capobianco, M.L.; Aluigi, A.; Kovtun, A.; Ruani, G.; Corticelli, F.; et al. Graphene oxide doped polysulfone membrane adsorbers for the removal of organic contaminants from water. Chem. Eng. J. 2017, 326, 130–140. [Google Scholar] [CrossRef]
  31. Zeng, Z.; Lyu, J.; Bai, P.; Guo, X. Adsorptive separation of fructose and glucose by metal–organic frameworks: Equilibrium, kinetic, thermodynamic, and adsorption mechanism studies. Ind. Eng. Chem. Res. 2018, 57, 9200–9209. [Google Scholar] [CrossRef]
  32. Peng, Y.; Zhang, Y.; Huang, H.; Zhong, C. Flexibility induced high-performance MOF-based adsorbent for nitroimidazole antibiotics capture. Chem. Eng. J. 2018, 333, 678–685. [Google Scholar] [CrossRef]
  33. Zhao, X.; Wei, Y.; Zhao, H.; Gao, Z.; Zhang, Y.; Zhi, L.; Wang, Y.; Huang, H. Functionalized metal-organic frameworks for effective removal of rocephin in aqueous solutions. J. Colloid. Interface Sci. 2018, 514, 234–239. [Google Scholar] [CrossRef] [PubMed]
  34. Zhao, X.; Wang, K.; Gao, Z.; Gao, H.; Xie, Z.; Du, X.; Huang, H. Reversing the dye adsorption and separation performance of metal–organic frameworks via introduction of –SO3H groups. Ind. Eng. Chem. Res. 2017, 56, 4496–4501. [Google Scholar] [CrossRef]
  35. Zhu, X.; Li, B.; Yang, J.; Li, Y.; Zhao, W.; Shi, J.; Gu, J. Effective adsorption and enhanced removal of organophosphorus pesticides from aqueous solution by Zr-based MOFs of UiO-67. ACS Appl. Mater. Interfaces 2015, 7, 223–231. [Google Scholar] [CrossRef]
  36. Zhou, Z.; Ke, Q.; Wu, M.; Zhang, L.; Jiang, K. Pore space partition approach of ZIF-8 for pH responsive codelivery of ursolic acid and 5-fluorouracil. ACS Mater. Lett. 2023, 5, 466–472. [Google Scholar] [CrossRef]
  37. Yue, D.; Li, G.; Li, F.; Chen, D.; Li, W.; Qin, B.; Zhang, B.; Zhang, Y.; Wang, Y.; Wang, Z. Zinc-based metal-organic frameworks as fluorescent probes for the detection of Vitamin B6. Dye. Pigment. 2023, 222, 111857. [Google Scholar] [CrossRef]
  38. Zhang, S.; Wang, J.; Zhang, Y.; Ma, J.; Huang, L.; Yu, S.; Chen, L.; Song, G.; Qiu, M.; Wang, X. Applications of water-stable metal-organic frameworks in the removal of water pollutants: A review. Environ. Pollut. 2021, 291, 118076. [Google Scholar] [CrossRef]
  39. Karimi, S.; Namazi, H. Efficient adsorptive removal of used drugs during the COVID-19 pandemic from contaminated water by magnetic graphene oxide/MIL-88 metal-organic framework/alginate hydrogel beads. Chemosphere 2024, 352, 141397. [Google Scholar] [CrossRef]
  40. Liang, R.; Luo, S.; Jing, F.; Shen, L.; Qin, N.; Wu, L. A simple strategy for fabrication of Pd@ MIL-100 (Fe) nanocomposite as a visible-light-driven photocatalyst for the treatment of pharmaceuticals and personal care products (PPCPs). Appl. Catal. B 2015, 176, 240–248. [Google Scholar] [CrossRef]
  41. Shah, S.S.A.; Khan, N.A.; Rehman, A.U.; Murtaza, G.; Ashiq, S.; Nazir, M.A.; Najam, T.; Sohail, M. Removal of antibiotics from wastewater via metal-organic frameworks (MOFs) as adsorbents. Toxin Rev. 2024, 43, 277–299. [Google Scholar] [CrossRef]
  42. Yu, S.; Pang, H.; Huang, S.; Tang, H.; Wang, S.; Qiu, M.; Chen, Z.; Yang, H.; Song, G.; Fu, D.; et al. Recent advances in metal-organic framework membranes for water treatment: A review. Sci. Total Environ. 2021, 800, 149662. [Google Scholar] [CrossRef] [PubMed]
  43. Johnson, B.A.; Bhunia, A.; Fei, H.; Cohen, S.M.; Ott, S. Development of a UiO-type thin film electrocatalysis platform with redox-active linkers. J. Am. Chem. Soc. 2018, 140, 2985–2994. [Google Scholar] [CrossRef] [PubMed]
  44. Hu, J.; Liu, Y.; Liu, J.; Gu, C.; Wu, D. High CO2 adsorption capacities in UiO type MOFs comprising heterocyclic ligand. Microporous Mesoporous Mater. 2018, 256, 25–31. [Google Scholar] [CrossRef]
  45. Ma, J.; Chen, Z.; Diao, Y.; Ye, M.; Liu, X.; Cui, S.; Zhong, M.; Nezamzadeh-Ejhieh, J.; Liu, J.; Ouyang, J. Current and promising applications of UiO-based MOFs in breast cancer therapy. React. Funct. Polym. 2024, 200, 105918. [Google Scholar] [CrossRef]
  46. Hang, C.; Akpinar, I.; Qin, Y.; Huang, L.; Wang, L.; Li, W.; Wu, J. A Review on Adsorption of Organic Pollutants from Water by UiO-67 and Its Derivatives. J. Nanoelectron. Optoelectron. 2021, 16, 1861–1873. [Google Scholar] [CrossRef]
  47. Ahmad, K.; Nazir, M.A.; Qureshi, A.K.; Hussain, E.; Najam, T.; Javed, M.S.; Shah, S.S.A.; Tufail, M.K.; Hussain, S.; Khan, N.A. Engineering of Zirconium based metal-organic frameworks (Zr-MOFs) as efficient adsorbents. Mater. Sci. Eng. B 2020, 262, 114766. [Google Scholar] [CrossRef]
  48. Flores-Cervantes, D.X.; Medina-Montiel, C.; Ramirez-Corona, N.; Navarro-Amador, R. Zirconium Based MOFs and Their Potential Use in Water Remediation: Current Achievements and Possibilities. Air Soil Water Res. 2022, 15, 11786221221080184. [Google Scholar] [CrossRef]
  49. Boudart, M. Adsorption assisted desorption in catalytic cycles. J. Mol. Catal. A Chem. 1999, 141, 1–7. [Google Scholar] [CrossRef]
  50. Lin, J.; Wang, L. Comparison between linear and non-linear forms of pseudo-first-order and pseudo-second-order adsorption kinetic models for the removal of methylene blue by activated carbon. Front. Environ. Sci. Eng. China 2009, 3, 320–324. [Google Scholar] [CrossRef]
  51. Ho, Y.-S.; McKay, G. Pseudo-second order model for sorption processes. Process Biochem. 1999, 34, 451–465. [Google Scholar] [CrossRef]
  52. Schaate, A.; Roy, P.; Godt, A.; Lippke, J.; Waltz, F.; Wiebcke, M.; Behrens, P. Modulated synthesis of Zr-based metal–organic frameworks: From nano to single crystals. Chem. A Eur. J. 2011, 17, 6643–6651. [Google Scholar] [CrossRef]
  53. Yan, F.; Wang, Q.; Wang, F.; Huang, Z. Study on energy storage properties of Metal-organic frameworks nanofluids (UIO-67/Water and UIO-67/Methanol) by an experimental and theoretical method. J. Mater. Sci. 2021, 56, 10008–10017. [Google Scholar] [CrossRef]
  54. Talha, K.; Wang, B.; Liu, J.-H.; Ullah, R.; Feng, F.; Yu, J.; Chen, S.; Li, J.-R. Effective adsorption of metronidazole antibiotic from water with a stable Zr (IV)-MOFs: Insights from DFT, kinetics and thermodynamics studies. J. Environ. Chem. Eng. 2020, 8, 103642. [Google Scholar]
  55. Saghir, S.; Wang, Y.; Xiao, Z. In situ synthesis of multivariant zeolitic tetrazolate imidazole frameworks (ZTIFs) with uncoordinated N-heteroatom sites for efficient adsorption of antiviral drugs. J. Clean. Prod. 2023, 414, 137654. [Google Scholar] [CrossRef] [PubMed]
  56. Dong, X.; Lin, Y.; Ma, Y.; Zhao, L. Ce-doped UiO-67 nanocrystals with improved adsorption property for removal of organic dyes. RSC Adv. 2019, 9, 27674–27683. [Google Scholar] [CrossRef] [PubMed]
  57. Thommes, M.; Kaneko, K.; Neimark, A.V.; Olivier, J.P.; Rodriguez-Reinoso, F.; Rouquerol, J.; Sing, K.S.W. Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report). Pure Appl. Chem. 2015, 87, 1051–1069. [Google Scholar] [CrossRef]
  58. Zambrano-Intriago, L.A.; Daza-López, E.V.; Fernández-Andrade, A.; Luque, R.; Amorim, C.G.; Araújo, A.N.; Rodríguez-Díaz, J.M.; Montenegro, M.C. Application of a novel hybrid MIL-53 (Al)@ rice husk for the adsorption of glyphosate in water: Characteristics and mechanism of the process. Chemosphere 2023, 327, 138457. [Google Scholar] [CrossRef]
  59. Rivadeneira-Mendoza, B.F.; Quiroz-Fernández, L.S.; da Silva, F.F.; Luque, R.; Balu, A.M.; Rodríguez-Díaz, J.M. Biomass@ MOF nanohybrid materials for competitive drug adsorption: Analysis by conventional macroscopic models and statistical physical models. Environ. Sci. Nano 2024, 11, 1543–1558. [Google Scholar] [CrossRef]
  60. Sánchez, N.C.; Palomino, G.T.; Cabello, C.P. Sulfonic-functionalized MIL-100-Fe MOF for the removal of diclofenac from water. Microporous Mesoporous Mater. 2023, 348, 112398. [Google Scholar] [CrossRef]
  61. Zhang, X.; Zhang, W.; Li, G.; Liu, Q.; Xu, Y.; Liu, X. A ratiometric fluorescent probe for determination of the anthrax biomarker 2, 6-pyridinedicarboxylic acid based on a terbium (III)−functionalized UIO-67 metal-organic framework. Microchim. Acta 2020, 187, 1–7. [Google Scholar] [CrossRef] [PubMed]
  62. Al-Khateeb, L.A.; Almotiry, S.; Salam, M.A. Adsorption of pharmaceutical pollutants onto graphene nanoplatelets. Chem. Eng. J. 2014, 248, 191–199. [Google Scholar] [CrossRef]
  63. Ahmed, S.H.; Rasheed, E.A.; Rasheed, L.A.; Abdulrahim, F.R. Decolorization of cationic dye from aqueous solution by Multiwalled Carbon Nanotubes. J. Ecol. Eng. 2024, 25, 72–84. [Google Scholar] [CrossRef]
  64. Negarestani, M.; Reisi, S.; Sohrabi, M.; Shayesteh, H.; Farimaniraad, H.; Mollahosseini, A.; Hosseinzadeh, M.; Tavassoli, S. In-situ growth of Al/Ni layered double hydroxide onto polyaniline-wrapped sisal fibers for highly efficient removal of pharmaceutical Ketoprofen and Ibuprofen contaminants: Batch and fixed-bed column studies. J. Water Process Eng. 2024, 57, 104657. [Google Scholar] [CrossRef]
  65. Finnouche, F.; Hamadi, A.; Kais, H.; Yeddou-Mezenner, N.; Nekkaa, Z. Efficient removal of hydroxychloroquine sulfate using cocoa shell activated carbon: A green approach investigating equilibrium, kinetics, and thermodynamics. J. Dispers. Sci. Technol. 2024, 1–11. [Google Scholar] [CrossRef]
Figure 1. XRD patterns of the simulated and synthesized UiO-67 (A), the mass changes in UiO−67 with temperature measured by TGA (B), the zeta potential measurement of UiO−67 (C), and N2 adsorption–desorption isotherms of UiO−67 at 77K (D).
Figure 1. XRD patterns of the simulated and synthesized UiO-67 (A), the mass changes in UiO−67 with temperature measured by TGA (B), the zeta potential measurement of UiO−67 (C), and N2 adsorption–desorption isotherms of UiO−67 at 77K (D).
Catalysts 14 00573 g001
Figure 2. TIR spectra of UiO-67 (A) and SEM images of UiO-67 (B,C).
Figure 2. TIR spectra of UiO-67 (A) and SEM images of UiO-67 (B,C).
Catalysts 14 00573 g002
Figure 3. Effect of different adsorbent mass (A), pH of solution (B), and solution temperature (C) on the elimination of RTV and LPV by UiO-67 from aqueous solution.
Figure 3. Effect of different adsorbent mass (A), pH of solution (B), and solution temperature (C) on the elimination of RTV and LPV by UiO-67 from aqueous solution.
Catalysts 14 00573 g003
Figure 4. The effect of contact time on the % removal and adsorption capacity of RTV and LPV from aqueous solution at 60 min by 50 mg UiO-67.
Figure 4. The effect of contact time on the % removal and adsorption capacity of RTV and LPV from aqueous solution at 60 min by 50 mg UiO-67.
Catalysts 14 00573 g004
Figure 5. Pseudo–first–order (A,B) and pseudo–second–order model (C,D) for the adsorption of RTV and LPV by UiO-67 at different temperatures.
Figure 5. Pseudo–first–order (A,B) and pseudo–second–order model (C,D) for the adsorption of RTV and LPV by UiO-67 at different temperatures.
Catalysts 14 00573 g005
Figure 6. Intra-particle diffusion (A,B) and liquid film diffusion model plots (C,D) for the adsorption of RTV and LPV by UiO-67 at different temperatures. (Experimental conditions: 10 mL sample volume and 50 mg UiO-67).
Figure 6. Intra-particle diffusion (A,B) and liquid film diffusion model plots (C,D) for the adsorption of RTV and LPV by UiO-67 at different temperatures. (Experimental conditions: 10 mL sample volume and 50 mg UiO-67).
Catalysts 14 00573 g006
Figure 7. Thermodynamic parameters for the adsorption of RTV and LPV by UiO−67. (Experimental conditions: 10 mL sample volume and 50 mg UiO−67).
Figure 7. Thermodynamic parameters for the adsorption of RTV and LPV by UiO−67. (Experimental conditions: 10 mL sample volume and 50 mg UiO−67).
Catalysts 14 00573 g007
Figure 8. Removal of RTV and LPV by UiO-67 from spiked environmental water samples.
Figure 8. Removal of RTV and LPV by UiO-67 from spiked environmental water samples.
Catalysts 14 00573 g008
Figure 9. The chemical structures of antivirals lopinavir (LPV) and ritonavir (RTV).
Figure 9. The chemical structures of antivirals lopinavir (LPV) and ritonavir (RTV).
Catalysts 14 00573 g009
Scheme 1. Synthesis UiO-67 metal-organic framework (MOF).
Scheme 1. Synthesis UiO-67 metal-organic framework (MOF).
Catalysts 14 00573 sch001
Figure 10. Chromatogram data of ritonavir and lopinavir at 254 nm.
Figure 10. Chromatogram data of ritonavir and lopinavir at 254 nm.
Catalysts 14 00573 g010
Table 1. Different kinetic models for the adsorption of ritonavir on UiO-67 at different temperatures.
Table 1. Different kinetic models for the adsorption of ritonavir on UiO-67 at different temperatures.
Pseudo-First-Order Kinetic Model
Temperatureqe,exp (mg/g)qe,calc (mg/g) k 1   ( m i n 1 ) R 2
294 K9.7071.0140.0240.620
308 K9.7180.6110.0470.662
322 K9.9520.9210.0460.826
Pseudo-Second-Order Kinetic Model
Temperatureqe,exp (mg/g)qe,calc (mg/g) k 2  (g/mg·min)h R 2
294 K9.7079.710.27425.8590.999
308 K9.7189.800.53951.8970.999
322 K9.9529.950.37236.8820.999
Liquid Film Diffusion Model
Temperaturekfd ( m i n 1 ) R 2
294 K0.0110.863
308 K0.0140.540
322 K0.0230.847
Intra-Particle Diffusion Model
Temperature k i d (mg/g· m i n 1 / 2 )C (mg/g) R 2
294 K0.3577.0380.224
308 K0.3846.9180.225
322 K0.3677.2500.223
Table 2. Different kinetic models for the adsorption of lopinavir on UiO-67at different temperatures.
Table 2. Different kinetic models for the adsorption of lopinavir on UiO-67at different temperatures.
Pseudo-First-Order Kinetic Model
Temperatureqe,exp (mg/g)qe,calc (mg/g) K 1   ( m i n 1 ) R 2
294 K9.00.5810.0260.495
308 K9.50.8660.0290.594
322 K9.60.7390.0290.563
Pseudo-Second-Order Kinetic Model
Temperatureqe,exp (mg/g)qe,calc (mg/g) K 2  (g/mg·min)h R 2
294 K9.08.9490.71957.5810.999
308 K9.59.4540.39835.5310.999
322 K9.69.5540.49344.9720.999
Liquid Film Diffusion Model
Temperaturekfd ( m i n 1 ) R 2
294 K0.0030.405
308 K0.0080.613
322 K0.0080.613
Intra-Particle Diffusion Model
Temperature k i d (mg/g· m i n 1 / 2 )C (mg/g) R 2
294 K0.3296.5690.219
308 K0.3676.7430.249
322 K0.3566.7440.227
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Almotiry, S.; Alhogbi, B.G.; Abdel Salam, M.; Jaremko, M. UiO-67 Metal–Organic Framework as Advanced Adsorbent for Antiviral Drugs from Water Environment. Catalysts 2024, 14, 573. https://doi.org/10.3390/catal14090573

AMA Style

Almotiry S, Alhogbi BG, Abdel Salam M, Jaremko M. UiO-67 Metal–Organic Framework as Advanced Adsorbent for Antiviral Drugs from Water Environment. Catalysts. 2024; 14(9):573. https://doi.org/10.3390/catal14090573

Chicago/Turabian Style

Almotiry, Sitah, Basma G. Alhogbi, Mohamed Abdel Salam, and Mariusz Jaremko. 2024. "UiO-67 Metal–Organic Framework as Advanced Adsorbent for Antiviral Drugs from Water Environment" Catalysts 14, no. 9: 573. https://doi.org/10.3390/catal14090573

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop